Several studies have revealed that the anti-OX40 and anti-GITR antibodies may facilitate the selective elimination of regulatory T cells in the tumor microenvironment by the effector functions of the antibody (12, 13). The gene discussed is TNFRSF18; the disease is neoplasm.